PaxMedica Inc. Skyrocketed
Mon, Sep 12, 2022 at 07:39 PM
PaxMedica Inc. (PXMD:NASDAQ) shot up at $4.33, a gain of 36.6%. On Mon, Sep 12, 2022, PXMD:NASDAQ hit a New 2-Week Intraday High of $5.47. The stock got featured on our News Catalysts scanner on Mon, Aug 29, 2022 at 06:04 AM in the 'BIOTECH' category. From Mon, Aug 29, 2022, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Fri, Sep 02, 2022 at $6.57 with a volume of 78M+.
About PaxMedica Inc. (PXMD:NASDAQ)
PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism...
Top 10 Gainers:
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 101.3%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 70.42%
- Ventyx Biosciences Inc. (VTYX:NASDAQ), 64.98%
- PolyPid Ltd. (PYPD:NASDAQ), 58.33%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 38.1%
- PaxMedica Inc. (PXMD:NASDAQ), 36.59%
- IDEAYA Biosciences, Inc. (IDYA:NASDAQ), 30.7%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 30.43%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 27.68%
- IHS Holding Limited (IHS:NYSE), 24.88%